Osteochondral Defect clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
open to eligible people ages 12-60
The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.
San Francisco, California and other locations
Our lead scientists for Osteochondral Defect research studies include Drew Lansdown, MD.
Last updated: